More than 1900 different mutations in the CFTR gene have been reported. These are grouped into classes according to their effect on the synthesis and/or function of the CFTR protein. CFTR repair therapies that are mutation or mutation class specific are under development. To progress efficiently in the clinical phase of drug development, knowledge of the relative frequency of CFTR mutation classes in different populations is useful. Therefore, we describe the mutation class spectrum in 25,394 subjects with CF from 23 European countries. In 18/23 countries, 80% or more of the patients had at least one class II mutation, explained by F508del being by far the most frequent mutation. Overall 16.4% of European patients had at least one class I mutation but this varied from 3 countries with more than 30% to 4 countries with less than 10% of subjects. Overall only respectively 3.9, 3.3 and 3.0% of European subjects had at least one mutation of classes III, IV and V with again great variability: 14% of Irish patients had at least one class III mutation, 7% of Portuguese patients had at least one class IV mutation, and in 6 countries more than 5% of patients had at least one class V mutation.

The relative frequency of CFTR mutation classes in European patients with cystic fibrosis / K.D. Boeck, A. Zolin, H. Cuppens, H.V. Olesen, L. Viviani. - In: JOURNAL OF CYSTIC FIBROSIS. - ISSN 1569-1993. - 13:4(2014 Jul), pp. 403-409. [10.1016/j.jcf.2013.12.003]

The relative frequency of CFTR mutation classes in European patients with cystic fibrosis

A. Zolin
Secondo
;
L. Viviani
Ultimo
2014

Abstract

More than 1900 different mutations in the CFTR gene have been reported. These are grouped into classes according to their effect on the synthesis and/or function of the CFTR protein. CFTR repair therapies that are mutation or mutation class specific are under development. To progress efficiently in the clinical phase of drug development, knowledge of the relative frequency of CFTR mutation classes in different populations is useful. Therefore, we describe the mutation class spectrum in 25,394 subjects with CF from 23 European countries. In 18/23 countries, 80% or more of the patients had at least one class II mutation, explained by F508del being by far the most frequent mutation. Overall 16.4% of European patients had at least one class I mutation but this varied from 3 countries with more than 30% to 4 countries with less than 10% of subjects. Overall only respectively 3.9, 3.3 and 3.0% of European subjects had at least one mutation of classes III, IV and V with again great variability: 14% of Irish patients had at least one class III mutation, 7% of Portuguese patients had at least one class IV mutation, and in 6 countries more than 5% of patients had at least one class V mutation.
Allele frequency; CFTR mutation classes; CFTR mutations; Cystic fibrosis; Genotype; Prevalence
Settore MED/01 - Statistica Medica
Article (author)
File in questo prodotto:
File Dimensione Formato  
The-relative-frequency-of-CFTR-mutation-classes-in-European-patients-with-cystic-fibrosis_2014_Journal-of-Cystic-Fibrosis.pdf

accesso riservato

Tipologia: Publisher's version/PDF
Dimensione 665.43 kB
Formato Adobe PDF
665.43 kB Adobe PDF   Visualizza/Apri   Richiedi una copia
Pubblicazioni consigliate

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/2434/250865
Citazioni
  • ???jsp.display-item.citation.pmc??? 47
  • Scopus 123
  • ???jsp.display-item.citation.isi??? 121
social impact